SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    D. H. Boggs, C. Tarabolous, C. G. Morris, A. Hanna, W. Burrows, N. Horiba, M. Suntharalingam, Analysis of pathological complete response rates with paclitaxel-based regimens in trimodality therapy for esophageal cancer, Diseases of the Esophagus, 2014, 27, 5
  2. 2
    Katsuhiko Higuchi, Shouko Komori, Satoshi Tanabe, Chikatoshi Katada, Mizutomo Azuma, Hiromichi Ishiyama, Tohru Sasaki, Kenji Ishido, Natsuya Katada, Kazushige Hayakawa, Wasaburo Koizumi, Definitive Chemoradiation Therapy With Docetaxel, Cisplatin, and 5-Fluorouracil (DCF-R) in Advanced Esophageal Cancer: A Phase 2 Trial (KDOG 0501-P2), International Journal of Radiation Oncology*Biology*Physics, 2014, 89, 4, 872

    CrossRef

  3. 3
    T. Rackley, T. Leong, M. Foo, T. Crosby, Definitive Chemoradiotherapy for Oesophageal Cancer — A Promising Start on an Exciting Journey, Clinical Oncology, 2014,

    CrossRef

  4. 4
    B. G. Main, S. Strong, A. G. McNair, S. J. Falk, T. Crosby, J. M. Blazeby, Reporting outcomes of definitive radiation-based treatment for esophageal cancer: a review of the literature, Diseases of the Esophagus, 2014, 27, 5
  5. 5
    Jing Liu, Jinbo Yue, Ligang Xing, Jinming Yu, Present status and progress of neoadjuvant chemoradiotherapy for esophageal cancer, Frontiers of Medicine, 2013, 7, 2, 172

    CrossRef

  6. 6
    Yong Bao, ShiLiang Liu, QiChao Zhou, PeiQiang Cai, Simone Anfossi, QiaoQiao Li, YongHong Hu, MengZhong Liu, JianHua Fu, TieHua Rong, Qun Li, Hui Liu, Three-dimensional conformal radiotherapy with concurrent chemotherapy for postoperative recurrence of esophageal squamous cell carcinoma: clinical efficacy and failure pattern, Radiation Oncology, 2013, 8, 1, 241

    CrossRef